Showing results (171-180 of 3,649) with videos related to
Sort By:
Pageof 365
Nature Clinical Practice. Endocrinology & Metabolism|January 24, 2007
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptorsPhilippe Gervois, Jean-Charles Fruchart, Bart StaelsCurrent Opinion in Lipidology|August 4, 1999
Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosisJ C Fruchart, P Duriez, B StaelsCurrent Opinion in Lipidology|September 23, 2003
Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and functionGiulia Chinetti, Jean-Charles Fruchart, Bart StaelsJournal of Cardiovascular Risk|September 12, 2001
PPARS in inflammation, atherosclerosis and thrombosisH Duez, J C Fruchart, B StaelsThe Journal of Endocrinology|May 26, 2001
Peroxisome proliferator-activated receptors in inflammation controlP Delerive, J C Fruchart, B StaelsZeitschrift Fur Kardiologie|May 26, 2001
Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wallG Chinetti, J C Fruchart, B StaelsInternational Journal of Clinical Practice. Supplement|July 23, 2005
Inflammation, dyslipidaemia, diabetes and PPars: pharmacological interest of dual PPARalpha and PPARgamma agonistsP Gervois, J C Fruchart, B StaelsPathologie-Biologie|April 1, 1983
[Methods of biochemical analysis in hyperliproproteinemias]J C Fruchart, V Clavey, G VanhoutteJournal of Virological Methods|September 1, 1996
A fluorescence-based quantitative PCR method for investigation of pseudorabies virus latencyR Thiery, C Pannetier, H J Rziha, et al.Evolution; International Journal of Organic Evolution|November 18, 2020
Branching patterns in phylogenies cannot distinguish diversity-dependent diversification from time-dependent diversificationThéo Pannetier, César Martinez, Lynsey Bunnefeld, et al.Pageof 365